Novo Nordisk Broadens Arsenal with Implant Deal and MASH Approval as Buyback Sustains Momentum
Novo Nordisk is fighting back against Eli Lilly’s encroachment on multiple fronts — through a novel long-acting implant…
Novo Nordisk’s Wegovy Broadens Its Reach: UK MASH Nod, Medicare Push, and a Billion-Dollar Parent
Novo Nordisk’s bestselling GLP-1 drug is no longer tethered solely to obesity. The Danish pharma giant has locked…